Stay updated on Magrolimab in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. The new screenshot shows the updated version label with no visible changes to study content.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, a minor metadata change with no impact on page content or usability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the page metadata.SummaryDifference0.0%

- Check77 days agoChange DetectedExpanded and revised the Locations section by adding state site listings (CA, CO, FL, IL, MA, MO, NY, NC, OH, OK, TN, TX, WI) and removing prior state entries. This changes which study sites are listed and where participants can enroll.SummaryDifference1%

- Check98 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not pertain to the study, and updated the revision to v3.3.2. Removed the previous note indicating PubMed publications are automatically created by ClinicalTrials.gov and linked to the study, with the revision updated to v3.2.0.SummaryDifference0.1%

- Check105 days agoChange DetectedThe funding-status notice at the top of the page was removed. This banner was a generic operating-status message not related to the study details.SummaryDifference0.2%

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.